Work

Supplementary Figure S9 from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Year: 2023

Type: supplementary-materials

Abstract: (A) Immunohistochemistry (IHC) staining of NECTIN4 protein in UMUC3-Control and UMUC3-NECTIN4 OE tumor xenografts. (B) Rabbit IgG isotype negative control of UMUC3-Control and UMUC3-NECTIN4 OE tumor xenografts.

DOI: 10.1158/1078-0432.22481568

Authors: Carissa E. Chu, Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu, Vadim S. Koshkin, Bradley A. Stohr, Maxwell V. Meng, Raj S. Pruthi, Terence W. Friedlander, Yair Lotan, Peter C. Black, Sima P. Porten, Felix Y. Feng, Jonathan Chou

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361890594

Cites:

Cited by:

Related to: 10